CELLVIE - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 79286017
Serial Number
79286017
Word Mark
CELLVIE
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2021-10-15
Filing Date
2019-12-18
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
FICKES, JERI J
Statements
Goods and Services
Preparations for medical purposes employing mitochondria; cardiovascular treatment preparations employing mitochondria; cardiovascular pharmaceuticals employing mitochondria used in treating arrhythmias; pharmaceutical and biological preparations for the treatment of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies, tumors or diabetes mitochondria for transplant purposes for medical use; pharmaceutical and biological preparations for the application of mitochondria transplantation for medical purposes in vessel and organ transplantations; implantable living tissue and mitochondria for the promotion of tissue growth, for medical use; mitochondria, for medical use; biological tissue cultures containing mitochondria for medical purposes; pharmaceutical and biological preparations containing mitochondria for tissue regeneration and protection for medical purposes; living cell components, namely, mitochondria, including genetically-modified mitochondria or pharmaceutically treated mitochondria, for medical use in humans and veterinary use in animals
Goods and Services
Prosthetic tissues based on mitochondria for parietal, vascular and visceral use; medical apparatus and devices for the processing of tissue- or cell-samples for the isolation of mitochondria or other cell components, namely, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from muscle tissue or other human or animal tissues, as well as from cells and cell cultures; filter for the isolation of cell components, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from cells for medical purposes; medical apparatus and devices for the transplantation or injection of cells or cell component, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles in humans or animals
Goods and Services
Scientific and technological services, namely, scientific and clinical research, analysis and testing in the field of mitochondrial isolation or transplantation; scientific and clinical research and development services in the field of mitochondria; conducting clinical trials for others in the field of cardiovascular diseases, ischemia-and reperfusion-injuries, heart transplantations, tumor treatments, mitochondrial myopathies analysis of human tissues for scientific and clinical research relating to mitochondria; scientific and clinical research, analysis and testing services relating to the isolation and cultivation of human and animal mitochondria
Goods and Services
Medical testing services for diagnostic and disease treatment purposes relating to cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of human or animal tissues for mitochondria transplant treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of cells and cell components in relation to mitochondria for diagnostic and treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors
Translation of Words in Mark
The wording "CELLVIE" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-05-22
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2020-05-22
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-05-22
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-05-22
Primary Code
044
Correspondences
Name
Bruce Londa
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1531875
International Registration Date
2019-12-18
International Publication Date
2020-05-21
International Renewal Date
2029-12-18
Auto Protection Date
2022-01-16
International Status
001 - Request for extension of protection established
International Status Date
2020-05-21
Priority Claimed In
True
Priority Claimed Date
2019-06-18
First Refusal In
True
Trademark Events
Event DateEvent Description
2020-05-21SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-05-22NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-05-22ASSIGNED TO EXAMINER
2020-05-26APPLICATION FILING RECEIPT MAILED
2020-05-28NON-FINAL ACTION WRITTEN
2020-05-29NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-06-29REFUSAL PROCESSED BY MPU
2020-06-29NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-07-17CORRECTION TRANSACTION RECEIVED FROM IB
2020-07-31REFUSAL PROCESSED BY IB
2020-10-16CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
2020-12-03TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-03-05ASSIGNED TO LIE
2021-03-05CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-03-05TEAS/EMAIL CORRESPONDENCE ENTERED
2021-03-29FINAL REFUSAL WRITTEN
2021-03-29FINAL REFUSAL E-MAILED
2021-03-29NOTIFICATION OF FINAL REFUSAL EMAILED
2021-10-15ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2021-10-15ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
2021-12-22NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2021-12-22NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2022-01-09NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB